How reproductive health laws affect people with chronic illnesses
Time-Sensitive Research to Assess the Effects of Reproductive Health Policy on the Health Outcomes of People with Chronic Diseases
This project looks at how changing reproductive health policies affect pregnant people and others of reproductive age who have chronic conditions like heart disease, cancer, or diabetes.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-11193280 on NIH RePORTER |
What this research studies
You may be asked to complete surveys or interviews about your reproductive health and experiences managing a chronic condition. The team will combine those responses with medical records and population-level data to track outcomes before and after state policy changes. They will also interview clinicians to understand how laws influence medical decisions for people with complex health needs. Together these methods aim to show whether policy changes raise or lower risks such as severe maternal complications and maternal death.
Who could benefit from this research
Good fit: People of reproductive age who have chronic medical conditions (for example, cardiovascular disease, cancer, or diabetes), including pregnant people with these conditions, would be ideal candidates to provide survey or interview information.
Not a fit: People without reproductive capacity (for example, postmenopausal individuals) or those without chronic conditions may not directly benefit from the findings.
Why it matters
Potential benefit: If successful, this work could guide safer policies and healthcare practices to reduce pregnancy complications and deaths among people with chronic illnesses.
How similar studies have performed: Some prior studies link reproductive policies to outcomes in the general population, but focused research on people with chronic illnesses is limited and this approach is relatively novel.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Talabi, Mehret Birru — University of Pittsburgh at Pittsburgh
- Study coordinator: Talabi, Mehret Birru
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.